Combine capsule and tablets
Latest Novartis AG Patents:
- CD19 and CD22 chimeric antigen receptors and uses thereof
- Treatment of cancer using GFR alpha-4 chimeric antigen receptor
- Tricyclic AKR1C3 dependent KARS inhibitors
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant FC fusion proteins
- Solid forms comprising an oxime ether compound, compositions and methods of use thereof
Description
FIG. 1 is a top plan view of a combined capsule and tablets showing our new design;
FIG. 2 is a side elevation thereof, the side opposite being substantially a mirror image; and,
FIG. 3 is a bottom plan view thereof.
The capsule of FIG. 1 has two parts, the lower part being the container, the upper part the cap. The overall shape of the design is cylindrical.
Claims
The ornamental design for a combined capsule and tablets, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
| D5045 | June 1871 | James |
| D31133 | July 1899 | Lantz |
| 1931765 | October 1933 | Leever |
| 3113076 | December 1963 | Jacobs |
| 3399803 | September 1968 | Oglevee et al. |
| 3508678 | April 1970 | Graham et al. |
| 3823843 | July 1974 | Stephens et al. |
| D235215 | May 1975 | Larsen |
| 3927195 | December 1975 | Messora |
| 4196564 | April 8, 1980 | Bodenmann et al. |
| 4196565 | April 8, 1980 | Bodenmann et al. |
| 4231211 | November 4, 1980 | Stampfer et al. |
| 4247006 | January 27, 1981 | Bodenmann et al. |
| 4263251 | April 21, 1981 | Voegle |
| D285837 | September 23, 1986 | Wittwer |
| D309505 | July 24, 1990 | Colton |
| 5587177 | December 24, 1996 | Grimberg |
| 5769267 | June 23, 1998 | Duynslager et al. |
| 5895662 | April 20, 1999 | Meyer |
| 6365183 | April 2, 2002 | Edgren et al. |
| D464425 | October 15, 2002 | Meron et al. |
| 27 22 805 | November 1978 | DE |
| 35 37 748 | May 1986 | DE |
| 198 35 346 | February 2000 | DE |
| 0 121 321 | October 1984 | EP |
| 0 143 524 | June 1985 | EP |
| 0 180 543 | May 1986 | EP |
| 0 243 930 | November 1987 | EP |
| 0 246 804 | November 1987 | EP |
| 0 435 726 | July 1991 | EP |
| 0 461 290 | December 1991 | EP |
| 0 649 651 | April 1995 | EP |
| 1 213 004 | June 2002 | EP |
| 1 582 385 | January 1981 | GB |
| 1 596 008 | August 1981 | GB |
| 57-080318 | May 1982 | JP |
| 2001-087354 | April 2001 | JP |
| 00/35419 | June 2000 | WO |
| 00/47160 | August 2000 | WO |
| 00/67747 | November 2000 | WO |
| 01/15688 | March 2001 | WO |
Patent History
Patent number: D520635
Type: Grant
Filed: Mar 15, 2004
Date of Patent: May 9, 2006
Assignee: Novartis AG (Basel)
Inventors: Jean-Daniel Bonny (Füllinsdorf), Stefan Hirsch (Lörrach), Oskar Kalb (Lörrach), Peter Pietzonka (Maisprach)
Primary Examiner: Charles A. Rademaker
Attorney: Gregory C. Houghton
Application Number: 29/201,410
Type: Grant
Filed: Mar 15, 2004
Date of Patent: May 9, 2006
Assignee: Novartis AG (Basel)
Inventors: Jean-Daniel Bonny (Füllinsdorf), Stefan Hirsch (Lörrach), Oskar Kalb (Lörrach), Peter Pietzonka (Maisprach)
Primary Examiner: Charles A. Rademaker
Attorney: Gregory C. Houghton
Application Number: 29/201,410
Classifications
